Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives

American Journal of Hypertension

Volumn 18, Issue 1, 2005, Pages 56-64

  Lamarre Cliche, Maxime ^a   De Champlain, Jacques ^a,b   Lacourcière, Yves ^c   Poirier, Luc ^c   Karas, Maria ^a   Larochelle, Pierre ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

antihypertensive agents; chronobiology; endocrinology; Hyperaldosteronism; hypertension

Indexed keywords

ALDOSTERONE; AMLODIPINE; RAMIPRIL; RENIN; TELMISARTAN;

ADULT; AGED; AMPLITUDE MODULATION; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY POSTURE; CIRCADIAN RHYTHM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDING; STATISTICAL SIGNIFICANCE; SUPINE POSITION;

ADULT; AGED; ALDOSTERONE; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; POSTURE; PROSPECTIVE STUDIES; RAMIPRIL; REFERENCE VALUES; RENIN; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 13244291587     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.08.025     Document Type: Article

References (33)

1. W.F. Young Jr Minireview primary aldosteronism-changing concepts in diagnosis and treatment Endocrinology 144 2003 2208 2213
2. V.M. Montori, W.F. Young Jr Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature Endocrinol Metab Clin North Am 31 2002 619 632 xi
3. B.J. Gallay, S. Ahmad, L. Xu, B. Toivola, R.C. Davidson Screening for primary aldosteronism without discontinuing hypertensive medications plasma aldosterone-renin ratio Am J Kidney Dis 37 2001 699 705
4. G.W. Liddle Analysis of circadian rhythms in human adrenocortical secretory activity Arch Intern Med 117 1966 739 743
5. N. Stern, J.R. Sowers, D. McGinty, E. Beahm, M. Littner, R. Catania, P. Eggena Circadian rhythm of plasma renin activity in older normal and essential hypertensive men relation with inactive renin, aldosterone, cortisol and REM sleep J Hypertens 4 1986 543 550
6. P. Hjemdahl Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension Pharmacol Toxicol 63 Suppl 1 1988 27 31
7. M. Lebel, P. Douville Active renin concentration and the aldosterone/renin ratio in screening primary aldosteronism Am J Hypertens 16 2003 253A
8. M.C. Racine, P. Douville, M. Lebel Functional tests for primary aldosteronism value of captopril suppression Curr Hypertens Rep 4 2002 245 249
9. F. Weber, O.E. Brodde, M. Anlauf, K.D. Bock Subclassification of human beta-adrenergic receptors mediating renin release Clin Exp Hypertens A 5 1983 225 238
10. T. Ishimitsu, J. Minami, T. Nishikimi, Y. Kawano, S. Takishita, K. Kangawa, H. Matsuo, H. Matsuoka Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects Hypertens Res 21 1998 15 22
11. T. Okuguchi, T. Osanai, T. Kamada, M. Kimura, K. Takahashi, K. Okumura Significance of sympathetic nervous system in sodium-induced nocturnal hypertension J Hypertens 17 1999 947 957
12. M. Stene, N. Panagiotis, M.L. Tuck, J.R. Sowers, D. Mayes, G. Berg Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration, and circadian changes in normal man J Clin Endocrinol Metab 51 1980 1340 1345
13. K. Olgaard, S. Madsen, J. Roosen, M. Hammer Circadian rhythm of plasma aldosterone and plasma renin activity in steroid and non-steroid treated kidney transplanted patients Scand J Clin Lab Invest 37 1977 431 437
14. M. Schambelan, N.L. Brust, B.C. Chang, K.L. Slater, E.G. Biglieri Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism J Clin Endocrinol Metab 43 1976 115 131
15. R. Takeda, I. Miyamori, M. Ikeda, H. Koshida, Y. Takeda, S. Yasuhara, T. Morise, H. Takimoto Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators J Steroid Biochem 20 1984 321 323
16. C. Beretta-Piccoli, P. Weidmann, A. Meier, M. Grimm, G. Keusch, Z. Gluck Effects of short-term norepinephrine infusion on plasma catecholamines, renin, and aldosterone in normal and hypertensive man Hypertension 2 1980 623 630
17. M.E. Safar, Y.A. Weiss, P.L. Corvol, J.E. Menard, G.M. London, P.L. Milliez Anti-hypertensive adrenergic-blocking agents effects on sodium balance, the renin-angiotensin system and haemodynamics Clin Sci Mol Med Suppl 2 1975 93s 95s
18. M. Stornello, E.V. Valvo, L. Scapellato, M. Nazzari Humoral and hemodynamic effects of nitrendipine versus clonidine in patients with essential hypertension Clin Ther 8 1986 510 519
19. G. Trasforini, A. Margutti, A. Valentini, M.R. Ambrosio, M. Bondanelli, R. Rossi, R. Pansini, E.C. degli Uberti Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system effects of administration of epinephrine and norepinephrine in healthy man Regul Pept 63 1996 57 61
20. M.F. Rousseau, O. Gurne, D. Duprez, W. Van Mieghem, A. Robert, S. Ahn, L. Galanti, J.M. Ketelslegers Beneficial neurohormonal profile of spironolactone in severe congestive heart failure results from the RALES neurohormonal substudy J Am Coll Cardiol 40 2002 1596 1601
21. J.L. Izzo Jr, D. Horwitz, W.J. Lawton, H.R. Keiser Fludrocortisone suppression of sympathetic nervous activity Clin Pharmacol Ther 33 1983 102 106
22. H. Armbruster, W. Vetter, R. Beckerhoff, J. Nussberger, H. Vetter, W. Siegenthaler Diurnal variations of plasma aldosterone in supine man relationship to plasma renin activity and plasma cortisol Acta Endocrinol (Copenh) 80 1975 95 103
23. J. Sassard, M. Vincent, G. Annat, C.A. Bizollon A kinetic study of plasma renin and aldosterone during changes of posture in man J Clin Endocrinol Metab 42 1976 20 27
24. G.P. Guthrie Jr, J. Genest, W. Nowaczynski, R. Boucher, O. Kuchel Dissociation of plasma renin activity and aldosterone in essential hypertension J Clin Endocrinol Metab 43 1976 446 448
25. S. Meisel, A. Shamiss, T. Rosenthal Clinical pharmacokinetics of ramipril Clin Pharmacokinet 26 1994 7 15
26. J.A. Millar, B.P. McGrath, P.G. Matthews, C.I. Johnston Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients Clin Sci (Lond) 61 1981 75 83
27. J.K. Doig, R.J. MacFadyen, C.S. Sweet, J.L. Reid Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers J Cardiovasc Pharmacol 25 1995 511 517
28. M.J. Brown, R.V. Hopper Calcium-channel blockade can mask the diagnosis of Conn's syndrome Postgrad Med J 75 1999 235 236
29. P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism Hypertension 40 2002 897 902
30. E.L. Bravo, R.C. Tarazi, H.P. Dustan, F.M. Fouad, S.C. Textor, R.W. Gifford, D.G. Vidt The changing clinical spectrum of primary aldosteronism Am J Med 74 1983 641 651
31. H. Vetter, W. Vetter Regulation of aldosterone secretion in primary aldosteronism Horm Metab Res 7 1975 418 424
32. M.T. Pham-Huu-Trung, J.M. Duclos, J.Y. Pagny, A. Bogyo, P. Leneuve, F. Girard In vitro studies in primary aldosteronism baseline steroid production and aldosterone responses to ACTH and angiotensin II Acta Endocrinol (Copenh) 117 1988 135 144
33. T. Mancini, B. Kola, F. Mantero, G. Arnaldi Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin J Clin Endocrinol Metab 88 2003 1994 1998